Financial Data and Key Metrics Changes - Adjusted net revenues for Q2 2025 were $405 million, with an operating margin of 18.1% and adjusted EPS of $2.95, all higher compared to the same period last year [5][19] - Advisory revenues reached $206 million during the quarter, up 12% year over year, driven by a higher average fee and an increase in completed transactions [5][6] - For the first half of 2025, net revenues totaled $789 million, with an operating income of $142 million and an operating margin of 18% [19][20] Business Line Data and Key Metrics Changes - Advisory revenues for the first half of 2025 were $423 million, up 24% compared to the previous year, with significant growth in M&A and non-M&A advisory services [6][20] - Corporate financing revenues were $35 million, down 31% year over year, with 26 financings completed, raising $10 billion for corporate clients [9][10] - Public finance revenues increased by 66% year over year to $42 million, driven by strong market conditions and demand [13] - Equity brokerage revenues were $58 million, a 12% increase year over year, with robust trading activity [15] - Fixed income revenues reached $54 million, up 37% from the previous year, driven by strong activity with depository clients [16] Market Data and Key Metrics Changes - The economic fee pool for companies with sub-five billion dollars market cap decreased by 19% year over year, with a notable 61% decline in the biopharma sector [10] - The municipal financing market saw a 15% growth in par value issuance, with Piper Sandler exceeding this growth with a 66% increase in revenues [13] Company Strategy and Development Direction - The company is focused on expanding its M&A business and enhancing its technology investment banking group through strategic acquisitions, such as the planned acquisition of G Squared Capital Partners [25][26] - Investments in non-M&A advisory capabilities are gaining traction, with total revenues from these product lines growing faster than overall advisory revenues [6][7] Management's Comments on Operating Environment and Future Outlook - Management noted a shift in market sentiment and improved client engagement, leading to a robust pipeline of announced and in-process transactions [4][9] - The outlook for advisory services is positive, with expectations for third-quarter advisory revenues to be consistent with the second quarter [9] - Management expressed confidence in the recovery of the IPO market, particularly in sectors like med tech and insurance, while noting challenges in the biotech IPO space [40][42] Other Important Information - The company repurchased approximately 85,000 shares for $21 million and paid $17 million in dividends during the quarter [23][24] - A restructuring charge of $5 million was included in GAAP results due to headcount reductions and vacated office space [18] Q&A Session Summary Question: What does a more normal bank consolidation market mean for revenue? - Management indicated that conditions for depository M&A are improving, with quicker regulatory approvals and an increase in transaction announcements expected to impact revenues positively [30][32] Question: How is the Avidity acquisition enhancing client connectivity? - Management reported that the acquisition has met expectations, enhancing relationships with senior partners and improving overall transaction activity [34][36] Question: What is the outlook for the IPO market, especially in biotech? - Management noted a general improvement in the IPO market but highlighted that biotech IPOs remain slow, requiring continued improvement before significant activity resumes [42][43] Question: How do the fixed income trading and bank M&A outlooks align? - Management clarified that the strong Q2 results in fixed income do not contradict the positive outlook for bank M&A, attributing the fixed income performance to large transactions [44][46] Question: How are conversations with sponsor clients evolving? - Management observed increased activity and a positive outlook for transactions, although caution remains in the process [55][56] Question: What is the confidence level in achieving the $2 billion investment banking target? - Management expressed confidence in achieving the target, citing diverse growth opportunities across various industry teams [57][61]

[Second Quarter 2025 Results Overview](index=1&type=section&id=Second%20Quarter%202025%20Results%20Overview) [Second Quarter 2025 Performance Summary](index=1&type=section&id=Second%20Quarter%202025%20Performance%20Summary) Piper Sandler reported strong Q2 2025 results with significant year-over-year revenue and EPS growth across both GAAP and adjusted metrics, alongside a dividend increase | Metric | U.S. GAAP | vs. Q2-24 | Adjusted (Non-GAAP) | vs. Q2-24 | | :--- | :--- | :--- | :--- | :--- | | Net Revenues | $397 million | 17% | $405 million | 14% | | Pre-tax Margin | 12.3% | +4.0pp | 18.1% | +0.8pp | | Net Income | $42 million | 21% | $53 million | 17% | | Diluted EPS | $2.38 | 21% | $2.95 | 17% | - The strong quarterly results were attributed to year-over-year revenue growth across many businesses, highlighting the benefits of product and sector diversification in a more constructive market environment[3](index=3&type=chunk) [Financial & Business Highlights](index=1&type=section&id=Financial%20%26%20Business%20Highlights) The company achieved robust revenue growth in key segments, pursued strategic acquisitions and talent acquisition, and returned **$189 million** to shareholders in H1 2025 - Key revenue drivers for Q2 2025 included: **Advisory services revenues of $206 million, up 12% YoY**; **Municipal financing revenues of $42 million**, the best quarter since 2021; and **Institutional brokerage revenues of $112 million, up 22% YoY**[6](index=6&type=chunk) - Strategic growth initiatives included the pending acquisition of G Squared Capital Partners and the hiring of several managing directors to strengthen various advisory groups[6](index=6&type=chunk) - Capital management included an increased quarterly cash dividend to **$0.70 per share** and a total of **$189 million** returned to shareholders in H1 2025 through repurchases and dividends[6](index=6&type=chunk) [U.S. GAAP Financial Results](index=2&type=section&id=U.S.%20GAAP%20Financial%20Results) [U.S. GAAP Selected Financial Data](index=2&type=section&id=U.S.%20GAAP%20Selected%20Financial%20Data) Q2 2025 U.S. GAAP net revenues increased **17%** to **$396.8 million**, with net income up **21%** to **$42.2 million** or **$2.38** per diluted share | U.S. GAAP (in thousands) | Q2 2025 | Q2 2024 | Change vs. Q2-24 | | :--- | :--- | :--- | :--- | | Net Revenues | $396,778 | $339,179 | 17% | | Total Non-interest Expenses | $347,854 | $310,933 | 12% | | Income Before Income Tax | $48,924 | $28,246 | 73% | | Net Income Attributable to Piper Sandler | $42,182 | $34,773 | 21% | | Earnings Per Diluted Share | $2.38 | $1.97 | 21% | | Business Metrics | Q2 2025 | Q2 2024 | Change vs. Q2-24 | | :--- | :--- | :--- | :--- | | Total Completed Advisory Transactions | 71 | 68 | 4% | | Municipal Negotiated Issues (Par Value) | $5.7 billion | $3.2 billion | 78% | | Equity Brokerage Shares Traded | 2.9 billion | 2.8 billion | 4% | [Detailed Revenue Analysis (GAAP)](index=3&type=section&id=Detailed%20Revenue%20Analysis%20(GAAP)) Q2 2025 total net revenues increased **17%** to **$396.8 million**, driven by **9%** growth in investment banking and **22%** in institutional brokerage | Revenue Segment (GAAP) | Q2 2025 ($M) | vs. Q2 2024 | | :--- | :--- | :--- | | Advisory Services | $206.2 | 12% | | Corporate Financing | $35.0 | -31% | | Municipal Financing | $41.9 | 66% | | **Total Investment Banking** | **$283.1** | **9%** | | Equity Brokerage | $58.1 | 12% | | Fixed Income Services | $54.3 | 37% | | **Total Institutional Brokerage** | **$112.4** | **22%** | - Significant growth in municipal financing was driven by increased issuance activity, while fixed income services benefited from increased depository client activity and balance sheet restructuring trades[13](index=13&type=chunk) [Expense and Profitability Analysis (GAAP)](index=4&type=section&id=Expense%20and%20Profitability%20Analysis%20(GAAP)) Total non-interest expenses increased **12%** to **$347.9 million**, yet the pre-tax margin improved to **12.3%** due to higher revenues and a lower compensation ratio - The compensation ratio decreased to **65.1%** from **69.2%** in Q2 2024, primarily due to higher net revenues[8](index=8&type=chunk)[19](index=19&type=chunk) - Non-compensation expenses increased **18% YoY**, driven by higher reimbursed deal expenses and **$5.0 million** in restructuring and integration costs[19](index=19&type=chunk) - The pre-tax margin expanded to **12.3%** in Q2 2025 from **8.3%** in Q2 2024, driven by revenue growth and a lower compensation ratio[16](index=16&type=chunk) [Non-GAAP Financial Results](index=5&type=section&id=Non-GAAP%20Financial%20Results) [Non-GAAP Selected Financial Data](index=5&type=section&id=Non-GAAP%20Selected%20Financial%20Data) Q2 2025 adjusted net revenues grew **14%** to **$405.4 million**, with adjusted operating income up **19%** to **$73.4 million** and diluted EPS at **$2.95** | Adjusted (Non-GAAP) (in thousands) | Q2 2025 | Q2 2024 | Change vs. Q2-24 | | :--- | :--- | :--- | :--- | | Adjusted Net Revenues | $405,388 | $356,710 | 14% | | Adjusted Total Operating Expenses | $332,016 | $295,116 | 13% | | Adjusted Operating Income | $73,372 | $61,594 | 19% | | Adjusted Net Income | $52,741 | $45,221 | 17% | | Adjusted Earnings Per Diluted Share | $2.95 | $2.52 | 17% | [Detailed Revenue, Expense, and Profitability Analysis (Non-GAAP)](index=6&type=section&id=Detailed%20Revenue%2C%20Expense%2C%20and%20Profitability%20Analysis%20(Non-GAAP)) Adjusted net revenues grew **14% YoY**, leading to an improved adjusted operating margin of **18.1%** due to higher revenues and a lower compensation ratio - Adjusted operating margin improved to **18.1%** in Q2 2025 from **17.3%** in Q2 2024, driven by higher adjusted net revenues and a lower adjusted compensation ratio[25](index=25&type=chunk) - The adjusted compensation ratio decreased to **62.0%** from **62.9%** in Q2 2024, reflecting operating leverage from higher adjusted net revenues[30](index=30&type=chunk) - Adjusted non-compensation expenses rose **14% YoY**, primarily due to higher reimbursed deal expenses and increased outside services costs[30](index=30&type=chunk) [Capital Management](index=6&type=section&id=Capital%20Management) [Dividends](index=6&type=section&id=Dividends) The company increased its quarterly cash dividend to **$0.70 per share** and returned **$87.3 million** to shareholders through dividends in H1 2025 - The quarterly cash dividend was increased by **$0.05** to **$0.70 per share**, payable on September 12, 2025[28](index=28&type=chunk) - Total dividends returned to shareholders in the first half of 2025 amounted to **$87.3 million**, or **$4.30 per share**[29](index=29&type=chunk) [Share Repurchases](index=7&type=section&id=Share%20Repurchases) In Q2 2025, the company repurchased **85,000 shares** for **$20.9 million**, contributing to **$101.5 million** in repurchases for H1 2025 - During Q2 2025, the company repurchased **$20.9 million** of its common stock (**85,000 shares**) at an average price of **$246.88 per share**[31](index=31&type=chunk) - For the first half of 2025, total share repurchases were **$101.5 million** (**351,000 shares**), with a significant portion covering tax obligations for vesting restricted stock awards[32](index=32&type=chunk) [Additional Information](index=7&type=section&id=Additional%20Information) [Human Capital and Shareholder Information](index=7&type=section&id=Human%20Capital%20and%20Shareholder%20Information) As of June 30, 2025, Piper Sandler had **1,845 full-time employees** and **182 corporate investment banking managing directors**, with common shareholders' equity at **$1.23 billion** | Metric | June 30, 2025 | June 30, 2024 | | :--- | :--- | :--- | | Full-time employees | 1,845 | 1,768 | | Corporate investment banking managing directors | 182 | 170 | | Common shareholders' equity | $1,229.9 million | $1,126.3 million | [Forward-Looking Statements](index=8&type=section&id=Forward-Looking%20Statements) This section contains forward-looking statements subject to significant risks and uncertainties, including market volatility and geopolitical conditions, which may cause actual results to differ materially - The company provides a cautionary note that forward-looking statements are not guarantees of future performance and are subject to risks detailed in its SEC filings[37](index=37&type=chunk)[38](index=38&type=chunk)[39](index=39&type=chunk) [Financial Statements and Reconciliations](index=9&type=section&id=Financial%20Statements%20and%20Reconciliations) [U.S. GAAP Results of Operations](index=9&type=section&id=U.S.%20GAAP%20Results%20of%20Operations) This section presents the unaudited consolidated statements of operations on a U.S. GAAP basis for the three and six months ended June 30, 2025 and 2024 [Non-GAAP Selected Summary Financial Information](index=10&type=section&id=Non-GAAP%20Selected%20Summary%20Financial%20Information) This section summarizes the company's adjusted, non-GAAP financial results for the three and six months ended June 30, 2025 and 2024, for comparative analysis [Reconciliation of U.S. GAAP to Non-GAAP Measures](index=11&type=section&id=Reconciliation%20of%20U.S.%20GAAP%20to%20Non-GAAP%20Measures) This section provides detailed reconciliation tables bridging U.S. GAAP to adjusted non-GAAP measures, including adjustments for investment losses, compensation, and restructuring costs

Company Performance - Piper Sandler Companies (PIPR) shares increased by 4.4% to close at $302.62, supported by solid trading volume, and have gained 11.5% over the past four weeks [1][2] - The stock has seen a price increase for two consecutive trading sessions, driven by growing investor optimism regarding investment banks due to a rebound in deal-making activities linked to clarity on Trump's tariff plans [2] Earnings Expectations - The company is expected to report quarterly earnings of $1.99 per share, reflecting a year-over-year decline of 21%, while revenues are projected to be $344.7 million, an increase of 1.6% from the previous year [3] - The consensus EPS estimate for Piper Sandler has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Piper Sandler belongs to the Zacks Financial - Investment Bank industry, which includes other companies like Citigroup (C), that closed 1.5% higher at $87.08, with a 9.5% return over the past month [5] - Citigroup's consensus EPS estimate has increased by 0.6% to $1.62, representing a year-over-year change of 6.6% [6]

Company Overview and Financial Performance - Piper Sandler Companies is a leading investment bank with over 60 offices and 1,800 employees[13] - The company's adjusted net revenues for the last twelve months (LTM) ending in the first quarter of 2025 were $1.6 billion[14] - Investment banking contributed $1.0 billion to the LTM 1Q 2025 adjusted net revenues[15] - Public finance generated $150 million in LTM 1Q 2025 adjusted net revenues[16] - Equity brokerage and fixed income contributed $220 million and $189 million respectively to the LTM 1Q 2025 adjusted net revenues[17] Strategic Investments and Growth - The company has consistently grown its platform through strategic investments, increasing adjusted net revenues from $599 million in 2015 to $1.59 billion in LTM 1Q 2025[22] - The average adjusted net revenues for 2023-2025* is $1.487 billion[26] - The average adjusted operating margin for 2023-2025* is 18.5%[28] - The average adjusted diluted EPS for 2023-2025* is $11.99[32] Market Position and Valuation - Piper Sandler is a top-ranked M&A advisor, having advised on over 1,030 M&A transactions worth more than $545 billion in the past 5 years[50] - The company's LTM revenue multiple is 2.9x, compared to an average of 4.3x for its peers[36] - Piper Sandler's public finance par value market share is 5.7% for LTM 1Q 2025[75]

Group 1 - The Value Lab focuses on long-only value investment ideas, targeting international mispriced equities with a portfolio yield of approximately 4% [1][2] - Piper Sandler reported a decent quarter, with Q1 benefiting from volatility in the brokerage business, and Q2 expected to continue this trend [2] - The Valkyrie Trading Society consists of analysts sharing high conviction investment ideas that are downside limited and likely to yield non-correlated and outsized returns in the current economic environment [3]

Financial Performance - Net revenues for the three months ended March 31, 2025, were $357,272,000, representing a 4.1% increase from $343,056,000 in the same period of 2024[180]. - Adjusted net revenues increased by 14.8% to $383,310,000 compared to $333,905,000 in the prior year[180]. - Net income attributable to Piper Sandler Companies rose by 52.8% to $64,915,000 from $42,493,000 year-over-year[180]. - Investment banking revenues increased 21.0% to $278.9 million, compared to $230.5 million in the prior-year period, with advisory services revenues up 37.9% to $216.8 million[194]. - Institutional brokerage revenues rose 8.5% to $99.3 million, with equity brokerage revenues increasing 9.6% to $54.3 million due to higher client activity[196]. - Interest income increased to $10.0 million, up 19.9% from $8.3 million in the prior-year period, primarily due to interest earned on installment fee receivables[197]. - Net income attributable to Piper Sandler Companies was $64.9 million, a 52.8% increase from $42.5 million in the prior-year period[189]. - The adjusted net revenues for the three months ended March 31, 2025, were $383.3 million, compared to $333.9 million in the first quarter of 2024[190]. - Earnings per diluted common share on a U.S. GAAP basis increased to $3.65 for the three months ended March 31, 2025, from $2.43 in the same period of 2024[224]. Tax and Expenses - The effective tax rate for the first quarter of 2025 was (24.9)%, compared to 5.4% in the same quarter of 2024[180]. - Non-interest expenses were $327.8 million, a 12.8% increase from $290.6 million in the prior-year period, with compensation and benefits expenses rising 11.7% to $248.5 million[201]. - Compensation and benefits expenses as a percentage of net revenues was 69.5% in Q1 2025, compared to 64.8% in Q1 2024, reflecting the impact of investment losses[202]. - Marketing and business development expenses increased by 25.2% to $13.5 million for the three months ended March 31, 2025, compared to $10.8 million in the same period of 2024[207]. - Deal-related expenses decreased to $5.5 million for the three months ended March 31, 2025, down from $6.4 million in the corresponding period of 2024[208]. - Trade execution and clearance expenses rose to $5.2 million for the three months ended March 31, 2025, compared to $4.9 million in the same period of 2024[209]. - Other operating expenses surged to $5.5 million in the first quarter of 2025, compared to $2.1 million in the same period of 2024[212]. - Pre-tax margin decreased to 8.2% for the three months ended March 31, 2025, down from 15.3% in the same period of 2024[213]. Market Activity and Outlook - The corporate financing activity declined significantly, with the healthcare economic fee pool decreasing over 60% year-over-year[185]. - Advisory services revenues are expected to decline in the second quarter of 2025 due to anticipated delays in new transaction announcements[184]. - The equity brokerage business benefited from increased volatility, with strong performance expected to continue as long as volatility persists[186]. - Municipal financing activity was robust in the first quarter of 2025, but has started slowly in the second quarter due to significant rate volatility[188]. - The company anticipates a strong rebound in M&A activity when market conditions stabilize, particularly with financial sponsors[184]. Shareholder Actions - The company declared a special cash dividend of $1.00 per share related to 2023, and regular dividends of $0.60, $0.65, and $3.00 per share for 2024 and 2025[232]. - The board authorized a stock repurchase program of up to $150.0 million through December 31, 2026, with no shares repurchased in the first quarter of 2025[234]. - In Q1 2025, the company purchased 266,060 shares at an average price of $303.05 per share, totaling $80.6 million[235]. - The company purchased a total of 266,060 shares of its common stock during the quarter ended March 31, 2025, at an average price of $303.05 per share, with a remaining repurchase authorization of $150 million[304]. Assets and Capital - Total assets as of March 31, 2025, were $1,820.5 million, down from $2,255.9 million as of December 31, 2024[236]. - The adjusted leverage ratio decreased to 1.4 as of March 31, 2025, from 1.9 as of December 31, 2024, primarily due to a decline in cash and cash equivalents[238]. - As of March 31, 2025, the company's net capital was $225.6 million, exceeding the minimum requirement by $224.6 million[250]. - The company maintained compliance with all covenants related to its unsecured and secured revolving credit facilities as of March 31, 2025[245]. - Piper Sandler Hong Kong Limited was in compliance with the liquid capital requirements of the Hong Kong Securities and Futures Commission as of March 31, 2025[254]. Risk Management - The company faces liquidity risk due to potentially illiquid inventory positions and the inability to timely access necessary funding sources[277]. - The company has a formal risk management process to identify, assess, and monitor strategic, market, liquidity, credit, operational, human capital, and legal risks[263]. - The audit committee oversees management's processes for identifying and evaluating major risks, including market and credit risks[264]. - The company monitors and manages market risk exposure through evaluation of spread DV01 and MMD basis risk for municipal securities[274]. - Credit spread risk is managed through hedging strategies, although these may not be effective in all market environments[282]. - As of March 31, 2025, the company has a concentrated counterparty credit exposure of $5.2 million, primarily related to interest rate swaps, with one counterparty representing 85.7% of this exposure[286]. - The company has developed policies to mitigate operational risk, including segregation of duties and independent risk management activities across various functions[289]. - Inflation affects the company's expenses, such as employee compensation and occupancy costs, which may not be recoverable in service pricing[294]. - Legal and regulatory risks are significant, with extensive regulations applicable to the company's business activities[292]. - The company emphasizes the importance of human capital, with risks associated with attracting and retaining qualified employees[291]. - Cybersecurity measures are in place to protect confidential information, with ongoing evaluations of risk management procedures[288]. - The company has established business continuity plans to cover critical processes across the organization[289]. Derivative Contracts and Investments - The total notional contract value of off-balance sheet arrangements as of March 31, 2025, is approximately $393.86 million, with $268.02 million in customer matched-book derivative contracts and $210.78 million in trading securities derivative contracts[257]. - The net fair value of derivative contracts was approximately $4.4 million as of March 31, 2025, compared to $3.3 million as of December 31, 2024[258]. - The company has committed capital of $35.6 million to certain investment entities, which generally have no specified call dates[261]. - As of March 31, 2025, the credit quality of long corporate fixed income securities shows 1.3% rated A and 1.5% rated BBB, while taxable and tax-exempt municipal securities show 12.1% rated AAA and 51.1% rated AA[281]. - A parallel 50 basis point adverse change in the market is estimated to result in a decrease of approximately $0.2 million in the carrying value of fixed income securities inventory as of March 31, 2025[272].

分组1 - Piper Sandler Companies reported quarterly earnings of $4.09 per share, exceeding the Zacks Consensus Estimate of $2.42 per share, and up from $2.79 per share a year ago, representing an earnings surprise of 69.01% [1] - The company posted revenues of $383.31 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 7.79%, compared to year-ago revenues of $343.06 million [2] - Over the last four quarters, Piper Sandler has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] 分组2 - The stock has underperformed, losing about 19.1% since the beginning of the year, while the S&P 500 has declined by 4.7% [3] - The current consensus EPS estimate for the coming quarter is $3.11 on revenues of $401.4 million, and for the current fiscal year, it is $14.14 on revenues of $1.72 billion [7] - The Zacks Industry Rank for Financial - Investment Bank is currently in the bottom 24% of over 250 Zacks industries, indicating potential challenges for the sector [8]

Financial Data and Key Metrics Changes - The company reported adjusted net revenues of $383 million for Q1 2025, reflecting a 15% increase compared to Q1 2024, but a 23% decline from the previous quarter [21][22] - The operating margin was 17.9%, with adjusted EPS of $4.9, both showing improvements year over year [6][22] - Operating income grew by 23% year over year, outpacing revenue growth [22] Business Line Data and Key Metrics Changes - Corporate Investment Banking revenues totaled $253 million, a 20% increase year over year, driven by advisory services which saw revenues of $217 million, a 38% increase [6][7] - Corporate financing revenues decreased by 32% year over year to $36 million due to a challenging equity underwriting environment [11][22] - Equity brokerage revenues increased by 10% year over year to $54 million, with trading volumes reaching 2.9 billion shares [18][22] - Fixed income revenues rose by 7% year over year to $45 million, driven by solid activity across most client verticals [19][22] Market Data and Key Metrics Changes - The municipal financing revenues increased by 27% year over year to $26 million, outpacing market issuance growth [15][22] - The health care fee pool for corporate financing decreased over 60%, indicating significant market challenges [11] Company Strategy and Development Direction - The company is focusing on increasing client engagement and leveraging its comprehensive suite of products to navigate market volatility [5][8] - There is a strategic emphasis on expanding industry and product capabilities to provide solutions across more sectors [8][13] - The company aims to maintain its position as a top three investment bank in middle market deal activity, which is expected to demonstrate greater resilience [13] Management's Comments on Operating Environment and Future Outlook - Management noted heightened volatility in equity and debt markets, leading to uncertainty in M&A deal cycles and delayed announcements [5][9] - The outlook for M&A is challenging, but certain sectors remain active, particularly service-based business models [9][10] - Management expressed optimism about a potential rebound in M&A activity when market conditions stabilize [10] Other Important Information - The company hired additional managing directors to expand into the infrastructure sector and enhance its health care investment banking team [12][22] - The Board approved a quarterly cash dividend of $0.65 per share, reflecting a commitment to shareholder returns [27] Q&A Session Summary Question: M&A conditions and market stability - Management indicated that M&A activity is sector-dependent, with some processes stalled due to market uncertainty, particularly in consumer sectors [31][32] Question: Outlook for depositories - Management expressed a more positive outlook for depositories, with recent transactions indicating potential for activity in 2025 [35][39] Question: Advisory revenue outlook - Management noted that while advisory revenues may decline in the near term, there are offsets from different industry groups, and many companies are prepared to launch transactions [62][64] Question: IPO pipeline and health care business - Management highlighted a good backlog in the IPO market, particularly in med tech, but noted that small-cap biotech stocks need to recover before significant activity can resume [78][80] Question: Fixed income trading activity - Management observed that volatility is creating uncertainty, leading to cautious behavior among clients, although some activity is seen in balance sheet restructurings [81]

Financial Data and Key Metrics Changes - The company reported adjusted net revenues of $383 million for Q1 2025, reflecting a 15% increase compared to Q1 2024, but a 23% decline from the previous quarter [21][22] - The operating margin was 17.9%, with adjusted EPS of $4.9, both showing improvements year over year [6][21] Business Line Data and Key Metrics Changes - Corporate Investment Banking revenues totaled $253 million, a 20% increase year over year, driven by advisory services which saw revenues of $217 million, up 38% [6][7] - Corporate financing revenues decreased by 32% year over year to $36 million due to a challenging equity underwriting environment [11][22] - Public finance generated $26 million in revenues, a 27% increase year over year, outpacing market issuance growth [15] - Equity brokerage revenues increased by 10% year over year to $54 million, while fixed income revenues rose by 7% to $45 million [18][19] Market Data and Key Metrics Changes - The equity markets experienced heightened volatility, impacting investor sentiment and leading to a more cautious approach in equity capital raising [10][11] - The municipal financing market showed robust activity, although recent rate volatility has posed challenges for pricing transactions [15][16] Company Strategy and Development Direction - The company aims to leverage its diversified product offerings and sector expertise to navigate market volatility and enhance client engagement [5][8] - There is a focus on expanding capabilities in infrastructure and healthcare sectors, with recent hires to strengthen these areas [12][13] - The company is positioned to capitalize on opportunities in the middle market, which typically shows greater resilience [13] Management's Comments on Operating Environment and Future Outlook - Management noted that while the near-term outlook remains uncertain, there is potential for a rebound in M&A activity once market conditions stabilize [9][10] - The company anticipates a decline in advisory revenues in Q2 but remains optimistic about the long-term outlook, particularly for financial sponsors [9][62] - Management emphasized the importance of CEO confidence in driving M&A activity, with a focus on sector-specific dynamics influencing transaction volumes [68] Other Important Information - The company repurchased approximately 266,000 shares for $81 million, maintaining a flat share count since 2021 [25][26] - A quarterly cash dividend of $0.65 per share was approved, to be paid on June 13 [27] Q&A Session Summary Question: M&A conditions and market stability - Management indicated that M&A activity is sector-dependent, with some processes stalled due to market uncertainty, particularly in consumer sectors [32][33] Question: Outlook for depositories - Management expressed a more positive outlook for depositories, with recent transactions indicating potential for increased activity [36] Question: Advisory revenue outlook - Management noted that while advisory revenues may decline in the near term, there are many transactions in the pipeline that could positively impact future quarters [62] Question: IPO pipeline and health care business - Management highlighted a backlog in the IPO market, particularly in med tech, but noted that small-cap biotech may take longer to recover [78] Question: Fixed income trading activity - Management observed that volatility is creating uncertainty, leading to cautious behavior among clients, although some activity is seen in balance sheet restructurings [79]

Financial Data and Key Metrics Changes - Piper Sandler reported adjusted net revenues of $383 million for Q1 2025, reflecting a 15% increase compared to Q1 2024, but a 23% decline from the previous quarter [21] - The operating margin was 17.9%, with adjusted EPS at $4.9, both showing improvements year over year [6][21] - Operating income grew by 23% year over year, indicating enhanced operational efficiency [22] Business Line Data and Key Metrics Changes - Corporate Investment Banking revenues reached $253 million, a 20% increase year over year, driven by advisory services which generated $217 million, up 38% [6][7] - Corporate financing revenues decreased by 32% year over year to $36 million, attributed to a weakened equity underwriting market [12] - Public finance revenues increased by 27% year over year to $26 million, outpacing market issuance growth [16] - Equity brokerage revenues rose by 10% year over year to $54 million, while fixed income revenues increased by 7% to $45 million [18][19] Market Data and Key Metrics Changes - The equity markets experienced heightened volatility, impacting investor sentiment and leading to a more cautious approach [5][12] - The health care fee pool for corporate financing decreased over 60%, reflecting significant market challenges [12] - The municipal financing market showed robust activity, although recent rate volatility has led to transaction postponements [16] Company Strategy and Development Direction - The company aims to leverage its diversified product offerings and sector expertise to navigate market uncertainties and enhance client engagement [5][8] - Piper Sandler is focused on expanding its capabilities in the infrastructure sector and enhancing its advisory services to capitalize on market opportunities [13][14] - The firm continues to rank as a top three investment bank in middle market deal activity, positioning itself for future growth [14] Management's Comments on Operating Environment and Future Outlook - Management noted that while the near-term outlook remains uncertain, there is potential for a rebound in M&A activity once market conditions stabilize [10][11] - The company anticipates a decline in advisory revenues in Q2 due to market volatility but expects certain sectors to remain active [10][60] - Management emphasized the importance of CEO confidence in driving M&A transactions, indicating that strategic clients are still interested in transacting [66] Other Important Information - The company repurchased approximately 266,000 shares for $81 million, maintaining a flat share count since 2021 [24] - A quarterly cash dividend of $0.65 per share was approved, to be paid on June 13 [25] Q&A Session Summary Question: M&A conditions and market stability - Management indicated that M&A activity is sector-dependent, with some processes stalled due to market uncertainty, particularly in consumer sectors [29][30] Question: Outlook for depositories - There is a more positive outlook for depositories, with recent transactions indicating potential for increased activity [34] Question: Advisory business countercyclicality - Management noted that debt capital markets and restructuring segments are growing faster than M&A, providing stability [44][46] Question: IPO pipeline and health care business - The IPO market is showing signs of improvement, but small-cap biotech remains challenged [75] Question: Fixed income trading activity - Volatility is creating uncertainty, leading to cautious behavior among clients, particularly in fixed income markets [77]